Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06820515

ATHNdataset Registry

The Hemophilia Treatment Center (HTC) where you receive care is working with The American Thrombosis and Hemostasis Network (ATHN) to look at the quality of life of people with blood disorders and problems.

Doctors, scientists, policymakers, and other health care providers need a large amount of information from a lot of people to answer scientific, public health, and policy questions about better ways to treat blood disorders. They will use the information from the ATHNdataset to answer these questions.

Recruiting

Interested in participating?

Request Info

Key information

About this study

Participants who agree to participate will let their health information be included in the ATHNdataset Registry, and the information will be updated regularly to reflect the participant's current health status. This registry includes collecting, storing and managing health information through a secure database. The following health information will be collected:

  • Demographics (e.g., age, gender, income, education/occupation)
  • The type of blood disorder you have
  • Date you were diagnosed, or symptoms began
  • Family history of the disorder
  • Testing and assessments
  • Physical exams
  • Height, weight
  • Vital signs, including blood pressure and heart rate
  • Laboratory tests (results from blood or urine testing, or biological specimens)
  • Genetic test results
  • Imaging results (X-rays, CT scans, etc.)
  • Pharmacokinetic testing results (how drugs are processed in the body)
  • Medications used and any problems with use
  • Types of bleeds, pain and clotting problems
  • Treatments that stop your bleeding or clotting problems from occurring or getting worse
  • Surgeries and/or procedures
  • Immunizations (vaccines)
  • Devices
  • Routine care visits and injuries (trauma)
  • Other illnesses and diseases you may have
  • Allergies
  • Patient-reported outcomes (PROs), questionnaires, and surveys
  • Payment details for treatment, including insurance companies and health plans

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any participant evaluated for or the potential to have a blood disorder who has an encounter with an ATHN Affiliate.
  • Participants of any age.
  • Participant is able to provide consent or assent; a Legally Authorized Representative (LAR) may provide consent on a participant's behalf if a participant is unable to provide self-consent

Exclusion criteria

  • Any participant unable to provide consent or assent to participate in the ATHNdataset

Treatment and study plan

Primary outcomes

  1. Comprehensive real-world clinical data registry analysis, research, advocacy, and public health reporting for the blood disorders community

    Time frame: 15 years

    The ATHNdataset Registry objective is to develop a secure, comprehensive registry of real-world clinical data to support standardized comprehensive health information for persons living with blood disorders and public health reporting for the blood disorders community

Secondary outcomes

  1. Contribute to scientific and public health reporting for the blood disorders community

    Time frame: 20 years

    By providing a comprehensive registry for physicians, scientists, policy makers, and other health care stakeholders who require a large pool of participant information to answer questions related to blood disorders treatments

Study contacts

Contact information is provided by the study sponsor or research team.

Carol Fedor, RN

CONTACT

[email protected]

8003602846 ext. 122

Emily Callegari, RN

CONTACT

[email protected]

8003602846 ext. 124

Sponsors and collaborators

Lead sponsor

American Thrombosis and Hemostasis Network

Network

Registry information

Official study title

American Thrombosis and Hemostasis Network ATHNdataset Registry

Important dates

Study start
2024
Primary completion
2054
Study completion
2055
First posted
Feb 11, 2025
Registry last updated
Apr 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.